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The reactive wine of the TGGHSL thioester bindmg motif of the first amino acid-activatmg domain of surfactm synthetase was replaced by alanine 
usmg site-dlrected mutagenesis. The multlenzyme from cells of the resulting mutant lost its ability for thioester formatlon with L-Glu and was 
therefore inactive in surfactin production The thiolation reactlons catalyzed by the other amino acid-activating domams of surfactin synthetase 
were not affected by the mutation. The results show that L-Glu 1s acatwated at the first domam of surfactm synthetase, and gwe further evidence 
that a serine restdue 1s essential for substrate amino acid actwatlon at the reactlon centers of peptide synthetases 
Surfactm synthetase: Btic~llus suht~h.s: Site-dlrected mutagenesis: Thloester binding: Reactive serine: Multlple carrier model 
1. INTRODUCTION 
The mechanism of non-ribosomal biosynthesis of nu- 
merous microbial peptides is compatible with the pol- 
yenzyme model suggested by F. Lipmann [l] and the 
thiotemplate mechanism [2-51. These models propose 
that (i) amino acid-activating domains are arranged in 
series along multifunctional polypeptide chains, (ii) 
each reaction center of the peptide-synthesizing mul- 
tienzyme is equipped with a specific sulfhydryl group to 
which the amino acid substrates are attached as thioe- 
sters, and (iii) the growing peptide chain is assembled 
by the action of 4’-phosphopantetheine as a carrier. 
Recent studies of gramicidin S synthetase showed 
that a serine may be required for covalent attachment 
of the substrate amino acids to each reaction center of 
the multienzyme system [6]. These serine residues are 
part of a LGG H/D S L/I motif which is highly con- 
served in the C-terminal region of each amino acid- 
activating domain of the peptide synthetases [7-l 11. The 
H/D S L/I core of this motif has been identified as the 
4’-phosphopantetheine binding site of acyl carrier pro- 
teins/domains of fatty acid and polyketide synthetases 
[6]. On the basis of these results, we proposed that there 
are multiple peripheral 4’-phosphopantetheine carriers 
forming the thioester activation centers of multifunc- 
tional peptide synthetases [6]. The existence of multiple 
peripheral carriers instead of a central 4’-phosphopan- 
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tetheine arm, as postulated in the original version of the 
thiotemplate model, leads to a new concept of the mech- 
anism of non-ribosomal peptide biosynthesis. To begin 
to test this hypothesis, modification of the site of car- 
boxylthioester formation in the first amino acid-activat- 
ing domain of surfactin synthetase was undertaken by 
site-directed mutagenesis. 
Surfactin is a cyclic lipopeptide of the following struc- 
ture: 
C ,{I ,,-CHCH,CO + L-Glu -+ L-Leu + o-Leu 
I 4 
O--L-Leu t D-Leu +- ~-Asp t L-Val 
Ullrich et al. [ 121 and Menkhaus et al. [13] recently 
showed that the biosynthesis of surfactin is catalyzed by 
a multienzyme system consisting of at least 4 enzyme 
components termed E,,, E,,. E2 and E,. Nakano et al. 
[ 141 demonstrated that the genes coding for this process 
are organized into an operon (srfA) in the genome of 
Bacillus subtilis. Recent genetic studies ([15], and G. 
Grandi, personal communications) confirmed that srfA 
encodes the peptide synthetase subunits that catalyze 
surfactin synthesis. The first gene, srfAA, encodes the 
enzyme E,,, which catalyzes the incorporation of Glu, 
Leu and D-Leu. The second gene, srfAB, encodes E,,, 
which catalyzes the incorporation of Val, Asp and D- 
Leu, while the third gene, srfAC, encodes E,, which 
catalyzes the incorporation of the last amino acid, Leu. 
E, is an acyl transferase catalyzing the binding and 
transfer of the j.?-hydroxy fatty acid substrate. The gene 
coding for this enzyme has not yet been identified. In 
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this report the analysis of a mutant svfA is presented 
that had undergone a substitution of the conserved 
serine for an alanine within the thiolation motif of the 
first amino acid-activating domain by site-specific mut- 
agenesis. 
2. MATERIALS AND METHODS 
2.1. Bacterial strains and plasm& 
The Escherlchia colz strain used for plasmid propagation was 
AG1514 [uraD139A(aru leu)7697 AlacX74galUK r- m+strA recA56 srl] 
(from A. Grossman). For Ml3 phage propagation. E. co11 strain 
MV1190 [A(lac proAB) thi supE A(srl- recA)306 :: TN10 (Tet’) F’ 
traD36proAB 1acP 1ucZ AA4151 was used. NK7085 [A(lucpro) nalA’lF 
lacZYA536 proA+ proB’ mutSlO4 :: Tn5 [16]] was used in the mut- 
agenesis procedure as previously described [17]. 0KB105 (pheA sfp) 
is a surfactin-producing strain of B. subtdis [I 71. Bacillus subtilis strain 
LAB848 [pheA sfp AsrfA :: pNAC14 (Phleo’)] is a srfA deletion mu- 
tant. Plasmid pNAC14 was constructed by first inserting a 1.5 kb 
EcoRI fragment of p223-21K into pMMN46 [14]. followed by replace- 
ment of the Sun fragment wtth a 0.7 kb PvuII fragment containing the 
ble gene [18] that confers phleomycm resistance. The integration of this 
plasmid into the chromosome of a Srf stram by double-crossover 
results in the deletion of approximately 17 kb of srfA DNA containmg 
the first four amino acid-activating domains. The construction of the 
mutant was confirmed by Southern hybridization analysis. 
2.2. Culture media 
YT broth (2 x). LB and DSM agar media. prepared as described 
previously [19], were used for routme culture of B. subtdis and E coli 
strains. Blood agar solid medmm was used for detection of surfactin 
production. Chloramphenicol resistant (Cm’) cells were selected as 
described previously [19]. The surfactm producer strain OKBIOS and 
the non-producmg Ser-to-Ala mutant LAB960-7 [loheA sfp srfAA1 (S 
to A)] were grown m Landy medium [20] supplemented with 2 mg/l 
L-Phe and 0.1% yeast extract for surfactm synthetase preparation. 
2.3. Rud~ochemlcnls. ubstrates. and materials for chromutographJ 
[?Z]-Labeled ammo acids were purchased from Amersham/Buchler 
(Braunschweig, Germany). Tetrasodium [“Plpyrophosphate was from 
DuPon/NEN (Bad Homburg, Germany). The thioester adduct of 3- 
hydroxytetradecanoic acid with coenzyme A was synthesized as re- 
ported [12]. AcA 34 was obtained from Serva (Heidelberg, Germany) 
and Mono Q HR 5/5 from Pharmacia (Freiburg, Germany). 
2.4. Oligonucleotide-directed mutagenesrs 
The mutagenesis was performed by the gapped duplex procedure 
[21]. The 0.85 kb Hi?zcIIIRsuI fragment of pMMN42 [14]. containing 
the TGGHSL motif of the first amino acid-activating domain of srfA. 
was inserted into M13mp9 to yield the plasmid, mCD13. the single- 
stranded form of which was used for mutagenesis. The oligonucleotide 
that was used, 5’-TGGCGGACATGCTTTAAAAGCCATGA-3’. 
contained the amino acylation motif with the alanine codon substi- 
tuted for the serine codon. The ohgonucleotide was designed so that 
the mutation would result in the introduction of a DrcrI site (Fig 1). 
E. colt NK7085 was used as the host for propagating the mutated 
sequence in phage M13. Potential mutant clones were screened by 
DraI digestion. The complete 0.85 kb fragment was sequenced to 
verify that the only base changes present were those created using the 
ohgonucleottde. 
2.5. Introduction of the mutation rnto B. subtihs 
A 0.69 kb NdeI-Su/I fragment containing the mutation from one 
of the mutant clones (pCD18) was used to replace the wild-type se- 
quence of pMMN42. a derivative of the integration vector pMMN13 
[14] that carries a selectable cat (chloramphenicol acetyl transferase) 
gene, and the presence of the mutation in the recombmant (pCD20) 
was once again screened by DruI digestion. The site of the mutation 
m this construct was too close to the Sun end. and a sufficient length 
of homology on either side of the mutation site was needed to Increase 
the probability of retention of the mutation at the chromosome follow- 
ing isolation of plasmid-less, Cm’ segregants. To achieve this, a 0.87 
kb BgflI-Still fragment of srfA DNA was subcloned upstream of the 
San-PstI fragment of pCD20, and the resultant plasmid (pCD23) was 
then used to transform OKB105, a surfactin-producing strain of B 
suhtrlu. followed by selection for chloramphemcol resistance. This 
integration event occurs by Campbell recombination which results in 
dtsruption of srfA and a consequent loss of surfactin production in this 
partial srfA diploid strain [LAB855 pheA sfp srfA :’ pCD23 (Cm’)]. 
2.6. Isolutzon oj Srf segregants of plasmid integrants 
The cells of B subtilu strain LAB855 were grown in 2 x YT medium 
at 37°C to late-log phase and subcultured a number of times. An 
overnight grown culture was diluted 100 x and chloramphenicol resis- 
tance was induced at a concentration of 0.5 ,&ml for 1 h followed by 
growth at a selective concentration of 5 pug/ml for another hour. The 
actively growing Cm’ cells were then killed by 2 mM o-cycloserine. a 
cell wall-synthesis inhibuor. Since chloramphenicol is bacteriostatic 
the culture was enriched for the chloramphenicol-sensitive (Cm’) cells. 
The cells were washed with 2 x YT. appropriately diluted and plated 
on a non-selective medium such as LB or DSM agar. 
2.7. Assuys 
Assays for (I) ATPP/PP, exchange measurements, (ti) thioester bind- 
mg of substrate ammo acids by surfactin synthetase, as well as (iii) in 
vitro formatton of surfactin were performed as described in [12]. The 
acyl transferase enzyme E, of surfactin synthetase was assayed as 
described [I 31. 
2.8. Enzyme purrficutlon 
The surfactm synthetase multienzyme system from the wild-type 
strain B subtile OKBl05 and the mutant LAB960-7 was prepared as 
reported [ 131. Its components E,. Ez, and E, were fractionated by gel 
filtration of the crude extracts on an uhrogel AcA 34 column (45 x 2.5 
cm). The multienzyme fraction E, was separated into E,, and E,, by 
high-resolution anion-exchange FPLC on Pharmacia Mono HR 5/5. 
3. RESULTS 
3.1. Mutagenesis of the TGGHSL motif in the first do- 
mairl of srfA and its affect on surfactin production 
In a previous study of the amino acid-activating do- 
mains of gramicidin S synthetase of B. brevis [6], the 
LGG H/D S L/I motif was shown to be involved in the 
covalent attachment of the activated substrate amino 
acid to the multienzyme (amino acylation). This highly 
conserved motif among peptide synthetases resembled 
the 4’-phosphopantetheine binding site of acyl carrier 
subunits of fatty acid synthetases and polyketide syn- 
thetases. Hence, it was hypothesized that its serine resi- 
due binds indirectly to the amino acid via a 4’-phospho- 
pantetheine adaptor molecule. In order to determine if 
the serine is required for amino acylation. the serine of 
the TGGHSL motif in the first domain of srfA was 
changed to an alanine by site-directed mutagenesis (see 
section 2). The mutation was introduced into the B. 
subtilis chromosome using an integrative plasmid con- 
ferring Cm’ insertion resulting in the formation of a Srf 
mutant (LAB855), which is diploid for the sequence that 
was subject to the mutagenesis procedure Cm” segre- 
gants were then isolated, some of which were Srf, hav- 
221 
Volume 315, number 3 FEBSLETTERS July 1993 
2 I-kb . 
* * 
‘S->A wbe( I 8.kb I 
Fig. 1. The Ser-to-Ala mutation results in a DraI recognition site. Southern hybridization analysis of DraI-digested chromosomal DNA from the 
Ser-to-Ala mutants, Srf segregants and wild-type cells was performed. Lane 1. wild-type; lanes 24, Srf segregants: lanes 5-l 1, mutants. Below 
the photograph is a map showing the positions of the Dral sites in the chromosome of the hild-type. Srf segregants, and the Ser-to-Ala mutants, 
Also shown is the location of the srfA region (1.8 kb) used as the hybridization probe. 
ing retained the wild-type srfA sequence, and some of 
which were Srf, having acquired the Ser-to-Ala muta- 
tion. The latter was identified by Southern hybridiza- 
tion (Fig. 1). Chromosomal DNA from OKB105, puta- 
tive revertants and mutants were digested with DruI. A 
radiolabeled RNA probe was synthesized using T7 
RNA polymerase and pMMN42 linearized with s&I as 
template. A 2.13 kb fragment was observed in the wild- 
type and in the Srf segregants. As seen in Fig. 1, the 
mutation indicated by an asterisk results in two DrrrI 
fragments (0.8 kb and 1.33 kb), of which only the 1.33 
kb fragment could be detected by the probe, probably 
due to greater overlap of their nucleotide sequences. 
These results confirmed the presence of the mutation in 
the Srf strains and its absence in the wild-type and in 
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the Srf segregants. The loss of surfactin production in 
the mutants strongly suggests that the serine residue is 
required for surfactin biosynthesis. 
3.2. Characterization of the surfactin multienzyme sys- 
tem from the Ser-to-Ala mutant LAB960-7 
Surfactin synthetase was isolated from the surfactin 
producer, OKB 105, and the non-producing mutant, 
LAB960-7, bearing the Ser-to-Ala substitution in the 
amino acylation site of the first amino acid-activating 
domain of srfA. In Fig. 2 this multienzyme system ob- 
tained from the mutant strain was separated by AcA 34 
gel filtration into 3 enzyme fractions, E,, EZ, and E,, as 
demonstrated recently for the wild-type [ 131. The thioe- 
ster incorporation of the amino acid substrates, Leu, 
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Fig. 2. AcA 34 gel filtration of the crude extracts from the &r-to-Ala mutant strain B suhtrlu LAB960-7. The multienzyme fractron E, of surfactm 
synthetase was detected by the thioester incorporation of ‘JC-labeled substrate ammo acids (Leu l ; Val 7; Asp l and Glu n ). The acyl transferase 
component. E,, was monitored by the DTNB assay (A) and by its activrty m surfactin formation (x). 
Val, Asp, and Glu, into E, was examined. Evidently, E, 
had lost the ability to incorporate Glu as a consequence 
of the Ser-to-Ala mutation in the first domain of sur- 
factin synthetase. Thioester formation with the other E, 
substrate amino acids was not affected by the mutation 
as they showed the pattern of amino acid incorporation 
of the wild-type multienzyme [12]. The leucine-activat- 
ing enzyme, E,, appeared as a shoulder at the right 
border of the E, peak. All components of surfactin syn- 
thetase were tested for their activities in the biosynthesis 
of surfactin using the complementary enzymes prepared 
from the OKBlOS reference strain. E, was completely 
inactive, while E? and E, showed similar activities as the 
corresponding enzymes from the wild-type strain, as 
demonstrated in Fig. 2 for the acyl transferase enzyme 
E,. 
In a recent report [13] it was demonstrated that E, 
consists of two multifunctional enzymes, E,, and E,,, 
which can be separated by high-resolution anion-ex- 
change FPLC, as shown in Fig. 3A-D. E,*, which ap- 
pears at higher ionic strength, incorporates Leu and Glu 
as thioesters in a molar ratio of approximately 2: 1. while 
E,, incorporates Leu, Val, and Asp. In Fig. 3A and B 
the thioester formation activities of both enzymes pre- 
pared from the surfactin producer OKBlOS (B) and as 
well as from the mutant strain, B. subtilis LAB960-7 
(A), were compared. Mutant EIA is completely lacking 
in thioester formation with Glu. In either case E,, 
shows similar amino acid incorporation effects. In Fig. 
3C it is shown that mutant E,, is also deficient in the 
Glu-dependent ATP-PP, exchange. In Fig. 3D the ac- 
tivities of E,, and EIB from the mutant strain were 
tested for surfactin synthesis using assay mixtures con- 
taining the complementary enzymes prepared from the 
wild-type B. subtilis OKBlOS. E,, from the mutant is 
active in product formation, while mutant E,* is inac- 
tive. 
4. DISCUSSION 
The aim of this study was to obtain further evidence 
for the participation of the reactive serines in substrate 
amino acid activation at the reaction centers of peptide 
synthetases by protein engineering techniques investi- 
gating surfactin synthetase from B. subtilis. The TGG 
HSL thioester site motif [6.1 l] in the first amino acid- 
activating domain of the srfA operon was mutationally 
altered by substituting the conserved serine for an alan- 
ine. The components E,,, E,, and E, of surfactin synthe- 
tase prepared from the Ser-to-Ala mutant B. subtilis 
LAB960-7, showed the same reaction pattern and simi- 
lar activities as the corresponding proteins from the 
wild-type strain, OKBlOS. Mutant E,,, however, lost 
the ability to thioesterify Glu and was therefore inactive 
in surfactin production, consistent with the complete 
loss of lipopeptide formation observed in vivo investi- 
gating whole mutant cells. In addition. the Glu-depend- 
ent ATP-PP,, exchange in the primary aminoacyl 
adenylate activation disappeared as a consequence of 
the Ser-to-Ala mutation. The Ser-to-Ala mutation, 
evidently, leads to a defect in the activation of Glu, 
possibly by inducing secondary effects on the sites func- 
tioning in primary adenylate formation. These results 
confirm that the serine in the LGG H/D S L/I motif 
plays a crucial role in substrate amino acid activation. 
From our data we conclude that the first amino acid- 
activating domain of surfactin synthetase bears the acti- 
vation site for Glu consistent with our previous finding 
that the acyl transferase, E,, initiates surfactin forma- 
tion by transfer of the P-hydroxy fatty acid substrate to 
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Fractrons 
Fig. 3. Separatron of the E, complex of surfactin synthetase into Its 
components E,, and E,, by high-resolution anion-exchange FPLC on 
Pharmacia Mono Q HR 5/5. The protems were eluted wrth a linear 
gradient of O-O.5 M NaCl in 50 mM Tns-HCl buffer, pH 7.5 contain- 
ing 5 mM dithioerythritol. Flow rate, 1 ml/min; fraction stze, 1 ml. (A 
and B) Comparison of the thtoester formation reacttons of E,, and 
E,, prepared from the Ser-to-Ala mutant strain B suhtrlis LAB960-7 
(A). and the wild-type strain B. subtrlrs 0KB105 (B) with Leu (0). Val 
(v). Asp (a), and Glu (m). (C) E,, and E,, from the mutant stram were 
tested for substrate amino acid-dependent ATP-PP, exchange reac- 
tions (Leu O; Val V; Asp G‘ and Glu 0). (D) Both enzymes obtamed 
from the mutant cells were detected by covalent incorporatton of Leu. 
Thereafter their activities in the biosynthests of surfactin (x) were 
determined using assay mixtures containmg the complementary en- 
zymes from the wild-type 0KB105. 
E,,, forming P-hydroxyacyl glutamic acid as the initia- 
tion product [13]. Considering this result and the activa- 
tion pattern of E,,, E,, and E,, the following sequence 
of events in the biosynthesis of surfactin can be inferred: 
E,, (U-AA) presumably elongates the hydroxyacyl glu- 
tamate intermediate forming the lipotripeptide /3-hy- 
droxyacylK%-Leu-D-Leu, which is transferred to E,, 
(srfAB), where the lipohexapeptide p-hydroxyacyl- 
Glu-Leu-D-Leu-Val-Asp-D-Leu is assembled. The ad- 
dition of Leu into position 7 and the cyclization of the 
complete chain by lactone formation between the car- 
boxy1 group of the terminal leucine and the hydroxyl 
function of thep-hydroxy fatty acid in the first position 
would be catalyzed by the enzyme E, (srfAC). This 
sequence of the intermediate steps in the biosynthesis of 
surfactin has to be confirmed by an analysis of the 
elongation and termination processes. 
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